← Evidence map

ArticleCancer cell international2021

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas.

Sidi Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33663520